Literature DB >> 12221638

Feline immunodeficiency virus vectors. Gene transfer to mouse retina following intravitreal injection.

Todd A Derksen1, Sybille L Sauter, Beverly L Davidson.   

Abstract

BACKGROUND: Transduction of the murine retinal pigmented epithelium (RPE) with adenovirus vectors requires technically difficult and invasive subretinal injections. This study tested the hypothesis that recombinant vectors based on feline immunodeficiency virus (FIV) could access the retina following intravitreal injection.
METHODS: FIV vectors expressing E. coli beta-galactosidase (FIVbetagal) were injected alone, or in combination with adenovirus vectors expressing eGFP, into the vitreous of normal mice and eyes evaluated for transgene expression. In further studies, the utility of FIV-mediated gene transfer to correct lysosomal storage defects in the anterior and posterior chambers of eyes was tested using recombinant FIV vectors expressing beta-glucuronidase. FIVbetagluc vectors were injected into beta-glucuronidase-deficient mice, an animal model of mucopolysacharridoses type VII.
RESULTS: The results of this study show that similar to adenovirus, both corneal endothelium and cells of the iris could be transduced following intravitreal injection of FIVbetagal. However, in contrast to adenovirus, intravitreal injection of FIVbetagal also resulted in transduction of the RPE. Immunohistochemistry following an intravitreal injection of an AdeGFP (adenovirus expressing green fluorescent protein) and FIVbetagal mixture confirmed that both viruses mediated transduction of corneal endothelium and cells of the iris, while only FIVbetagal transduced cells in the retina. Using the beta-glucuronidase-deficient mouse, the therapeutic efficacy of intravitreal injection of FIVbetagluc (FIV expressing beta-glucuronidase) was tested. Intravitreal injection of FIVbetagluc to the eyes of beta-glucuronidase-deficient mice resulted in rapid reduction (within 2 weeks) of the lysosomal storage defect within the RPE, corneal endothelium, and the non-pigmented epithelium of the ciliary process. Transgene expression and correction of the lysosomal storage defect remained for at least 12 weeks, the latest time point tested.
CONCLUSION: These studies demonstrate that intravitreal injection of FIV-based vectors can mediate efficient and lasting transduction of cells in the cornea, iris, and retina. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12221638     DOI: 10.1002/jgm.267

Source DB:  PubMed          Journal:  J Gene Med        ISSN: 1099-498X            Impact factor:   4.565


  7 in total

1.  Integration site choice of a feline immunodeficiency virus vector.

Authors:  Yubin Kang; Christopher J Moressi; Todd E Scheetz; Litao Xie; Diane Thi Tran; Thomas L Casavant; Prashanth Ak; Craig J Benham; Beverly L Davidson; Paul B McCray
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

2.  Efficient gene transfer to retinal pigment epithelium cells with long-term expression.

Authors:  Lingyun Cheng; Mitsuko Toyoguchi; David J Looney; Jeffery Lee; Marie C Davidson; William R Freeman
Journal:  Retina       Date:  2005 Feb-Mar       Impact factor: 4.256

Review 3.  Human gene therapy vectors derived from feline lentiviruses.

Authors:  Román A Barraza; Eric M Poeschla
Journal:  Vet Immunol Immunopathol       Date:  2008-01-19       Impact factor: 2.046

4.  Transient immunosuppression stops rejection of virus-transduced enhanced green fluorescent protein in rabbit retina.

Authors:  Kentaro Doi; Jian Kong; Janos Hargitai; Stephen P Goff; Peter Gouras
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

5.  Retinal transduction profiles by high-capacity viral vectors.

Authors:  A Puppo; G Cesi; E Marrocco; P Piccolo; S Jacca; D M Shayakhmetov; R J Parks; B L Davidson; S Colloca; N Brunetti-Pierri; P Ng; G Donofrio; A Auricchio
Journal:  Gene Ther       Date:  2014-07-03       Impact factor: 5.250

Review 6.  Non-Primate Lentiviral Vectors and Their Applications in Gene Therapy for Ocular Disorders.

Authors:  Vincenzo Cavalieri; Elena Baiamonte; Melania Lo Iacono
Journal:  Viruses       Date:  2018-06-09       Impact factor: 5.048

Review 7.  Gene Therapy Applications of Non-Human Lentiviral Vectors.

Authors:  Altar M Munis
Journal:  Viruses       Date:  2020-09-29       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.